FDMT
4D Molecular Therapeutics, Inc.
12.69
2 x 9.65
2 x 16.15
bid
ask
-
0.61
4.59%
2 @ 08:42 AM
12.69 +0.00 (0.00%)
| Ytd | 69.20% | |
| 1y | 205.78% |
12.57
day range
13.53
3.86
52 week range
14.00
| Open | 13.30 | Prev Close | 13.30 | Low | 12.57 | High | 13.53 | Mkt Cap | 663.39M |
| Vol | 1.07M | Avg Vol | 862.53K | EPS | -2.57 | P/E | N/A | Forward P/E | -1.79 |
| Beta | 2.80 | Short Ratio | 9.86 | Inst. Own | 115.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 9.75 | 200-d Avg | 9.44 | 1yr Est | 42.64 |
| Income Statement | |||
| Total Revenue | 3.05M | ||
| Revenues (USD) | 3.05M | ||
| Gross Profit | 3.05M | ||
| Operating Expenses | 76.67M | ||
| Research and Development Expense | 64.98M | ||
| Selling, General and Administrative Expense | 11.69M | ||
| Operating Income | -73.62M | ||
| Net Income | -68.76M | ||
| Net Income Common Stock | -68.76M | ||
| Net Income Common Stock (USD) | -68.76M | ||
| Consolidated Income | -68.76M | ||
| Earnings per Basic Share | -1.01 | ||
| Earnings per Basic Share (USD) | -1.01 | ||
| Earnings per Diluted Share | -1.01 | ||
| Earning Before Interest & Taxes (EBIT) | -68.76M | ||
| Earning Before Interest & Taxes (USD) | -68.76M | ||
| Weighted Average Shares | 68.06M | ||
| Weighted Average Shares Diluted | 68.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 72.49M | ||
| Cash and Equivalents (USD) | 72.49M | ||
| Investments | 385.14M | ||
| Investments Current | 318.40M | ||
| Investments Non-Current | 66.74M | ||
| Current Assets | 405.36M | ||
| Property, Plant & Equipment Net | 30.94M | ||
| Total Assets | 512.91M | ||
| Debt Current | 5.49M | ||
| Total Debt | 20.54M | ||
| Current Liabilities | 43.40M | ||
| Debt Non-Current | 15.05M | ||
| Total Liabilities | 61.07M | ||
| Accumulated Retained Earnings (Deficit) | -785.06M | ||
| Accumulated Other Comprehensive Income | -180.00K | ||
| Shareholders Equity | 451.84M | ||
| Shareholders Equity (USD) | 451.84M | ||
| Assets Non-Current | 107.54M | ||
| Total Debt (USD) | 20.54M | ||
| Deferred Revenue | 2.49M | ||
| Liabilities Non-Current | 17.67M | ||
| Trade and Non-Trade Payables | 14.69M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.06M | ||
| Net Cash Flow from Financing | 11.48M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 12.25M | ||
| Capital Expenditure | 11.00K | ||
| Issuance (Purchase) of Equity Shares | 11.48M | ||
| Net Cash Flow from Investing | 68.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 68.88M | ||
| Net Cash Flow from Operations | -68.12M | ||
| Share Based Compensation | 4.45M | ||